VeriMom¿Es n-prolyl palmitoyl tripeptide-56 acetate seguro durante el embarazo?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
Pregnancy-safe products containing n-prolyl palmitoyl tripeptide-56 acetate
Related ingredients
Frequently asked questions
- ¿Es n-prolyl palmitoyl tripeptide-56 acetate seguro durante el embarazo?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
- ¿Es n-prolyl palmitoyl tripeptide-56 acetate seguro durante la lactancia?
- Same rationale as pregnancy: no reproductive or lactation-specific hazard identified in authoritative sources. No evidence of transfer in milk; dermal exposure from cosmetics is expected to be low but measurable (e=1). Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- ¿Es n-prolyl palmitoyl tripeptide-56 acetate seguro para la piel del bebé?
- No infant‑specific hazard data located. Because the ingredient likely has low but measurable dermal absorption in adults (e=1) and infant skin has higher permeability and higher surface‑area‑to‑weight, exposure score is increased by +1 to e=2 for 0–3 year olds. No studies demonstrating infant toxicity were found. Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- ¿Cómo puntúa VeriMom a n-prolyl palmitoyl tripeptide-56 acetate?
- VeriMom puntúa n-prolyl palmitoyl tripeptide-56 acetate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a n-prolyl palmitoyl tripeptide-56 acetate en el embarazo?
- Consulta nuestra lista de alternativas seguras a n-prolyl palmitoyl tripeptide-56 acetate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.